Abstract 553: Inhibition of Microrna-21 Prevents Myocardial Remodelling and Dysfunction in a Pig Model of Ischemia/reperfusion Injury
Deepak Ramanujam(Technical University of Munich), Stefan Engelhardt(Heidelberg University), Thomas Thum(Medizinische Hochschule Hannover), Katharina Klett(TUM Klinikum), Anne Dueck(German Centre for Cardiovascular Research), Rabea Hinkel(German Primate Center), Karl‐Ludwig Laugwitz(TUM Klinikum), Christian Kupatt(München Klinik), Veronika Kazcmarek(TUM Klinikum), Andrea Howe(TUM Klinikum)
Cited by 1
Related Papers
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
|Nature|2008|2.4k
Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
|Journal of Clinical Investigation|2014|993
MicroRNAs in the Human Heart
|Circulation|2007|888
Progressive hypertrophy and heart failure in β <sub>1</sub> -adrenergic receptor transgenic mice
|Proceedings of the National Academy of Sciences|1999|787
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767